Controversies over colloidal silver.
Lansdown
A B G
AB
D000287:Administration, Topical; D003102:Colloids / Q000494:pharmacology*; D017277:Drug Approval; D006801:Humans; D004366:Nonprescription Drugs; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D018030:Silver Compounds / Q000494:pharmacology*; D006113:United Kingdom; D014945:Wound Healing / Q000187:drug effects; D014946:Wound Infection / Q000517:prevention & control; D014947:Wounds and Injuries / Q000188:drug therapy*
D003102:Colloids; D004366:Nonprescription Drugs; D018030:Silver Compounds